These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12429313)

  • 21. Continuing or discontinuing low-dose aspirin before transrectal prostate biopsy: results of a prospective randomized trial.
    Giannarini G; Mogorovich A; Valent F; Morelli G; De Maria M; Manassero F; Barbone F; Selli C
    Urology; 2007 Sep; 70(3):501-5. PubMed ID: 17688919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of fluoroquinolone-resistant rectal flora in patients undergoing transrectal ultrasound-guided prostate needle biopsy: A prospective multicenter study.
    Chung HS; Hwang EC; Yu HS; Jung SI; Lee SJ; Lim DH; Cho WJ; Choe HS; Lee SJ; Park SW
    Int J Urol; 2018 Mar; 25(3):278-283. PubMed ID: 29241300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program.
    Raaijmakers R; Kirkels WJ; Roobol MJ; Wildhagen MF; Schrder FH
    Urology; 2002 Nov; 60(5):826-30. PubMed ID: 12429309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic value of percent free prostate-specific antigen: retrospective analysis of a population-based screening study with emphasis on men with PSA levels less than 3.0 ng/mL.
    Törnblom M; Norming U; Adolfsson J; Becker C; Abrahamsson PA; Lilja H; Gustafsson O
    Urology; 1999 May; 53(5):945-50. PubMed ID: 10223488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic significance of digital rectal examination and transrectal ultrasonography in men with prostate-specific antigen levels of 4 NG/ML or less.
    Yamamoto T; Ito K; Ohi M; Kubota Y; Suzuki K; Fukabori Y; Kurokawa K; Yamanaka H
    Urology; 2001 Dec; 58(6):994-8. PubMed ID: 11744475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risks and complications of transrectal ultrasound guided prostate needle biopsy: a prospective study and review of the literature.
    Rodríguez LV; Terris MK
    J Urol; 1998 Dec; 160(6 Pt 1):2115-20. PubMed ID: 9817335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prospective validation of a nomogram predictive of a positive initial prostate biopsy].
    Ramírez-Backhaus M; Bahilo P; Arlandis S; Santamaría Navarro C; Pontones Moreno JL; Jiménez-Cruz F
    Actas Urol Esp; 2010 Jan; 34(1):35-42. PubMed ID: 20223131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparison of ultrasound-guided transrectal and transperineal prostate biopsies in clinical application].
    Yuan LR; Zhang CG; Lu LX; Ruan L; Lan JH; Feng SQ; Luo JD
    Zhonghua Nan Ke Xue; 2014 Nov; 20(11):1004-7. PubMed ID: 25577836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Severe rectal bleeding after transrectal US-guided prostate biopsy. Case report].
    Geraci G; Sciumè C; Pisello F; Facella T; Modica G
    G Chir; 2006; 27(8-9):321-3. PubMed ID: 17064492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety of 12 core transrectal ultrasound guided prostate biopsy in patients on aspirin.
    Vasudeva P; Kumar N; Kumar A; Singh H; Kumar G
    Int Braz J Urol; 2015; 41(6):1096-100. PubMed ID: 26742966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Single and Prolonged Fluoroquinolone Prophylaxis and Risk Factors for Infectious Complications After Transrectal Prostate Biopsy.
    Kalkanlı A; Gezmiş CT; Özkan A; Çilesiz NC; Yanaral F; Aydın M; Tandoğdu Z
    Balkan Med J; 2018 Sep; 35(5):373-377. PubMed ID: 29866640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High detection rate of significant prostate tumours in anterior zones using transperineal ultrasound-guided template saturation biopsy.
    Mabjeesh NJ; Lidawi G; Chen J; German L; Matzkin H
    BJU Int; 2012 Oct; 110(7):993-7. PubMed ID: 22394668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Results of a screening program for prostate cancer in patients scheduled for abdominoperineal resection for colorectal pathologic findings.
    Terris MK; Wren SM
    Urology; 2001 May; 57(5):943-5. PubMed ID: 11337299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of rectal examination, prostatic massage, ultrasonography and needle biopsy on serum prostate specific antigen levels.
    Yuan JJ; Coplen DE; Petros JA; Figenshau RS; Ratliff TL; Smith DS; Catalona WJ
    J Urol; 1992 Mar; 147(3 Pt 2):810-4. PubMed ID: 1371553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Value of prostate-specific antigen (PSA) mass ratio in the detection of prostate cancer in men with PSA levels of ≤10 ng/mL.
    Hong SK; Oh JJ; Byun SS; Hwang SI; Choo MS; Lee SE
    BJU Int; 2012 Jul; 110(2 Pt 2):E81-5. PubMed ID: 22093144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng./ml.: a comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests.
    Mäkinen T; Tammela TL; Hakama M; Stenman UH; Rannikko S; Aro J; Juusela H; Määttänen L; Auvinen A
    J Urol; 2001 Oct; 166(4):1339-42. PubMed ID: 11547069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of prostate cancer in aging males receiving PSA (prostate specific antigen) screening test (A campaign for celebration of Siriraj Established Day).
    Srinualnad S; Charoenkraikamol C; Toraksa S; Uiprasertkul M; Amornvesukit T; Taweemonkongsap T; Udompunturak S; Nualyong C; Tantiwong A
    J Med Assoc Thai; 2006 Jan; 89(1):37-42. PubMed ID: 16583579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Puncture biopsy of the prostate].
    Lechevallier E
    Prog Urol; 1996; 6(4):507-18. PubMed ID: 8924925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical efficacy of transrectal ultrasound-guided prostate biopsy in men younger than 50 years old with an elevated prostate-specific antigen concentration (>4.0 ng/mL).
    Lu CH; Lin TP; Shen SH; Huang YH; Chung HJ; Kuo JY; Huang WJS; Wu HHH; Chang YH; Lin ATL; Chen KK
    J Chin Med Assoc; 2017 Jul; 80(7):413-418. PubMed ID: 28529023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biopsy indication--a predictor of pathologic stage among men with preoperative serum PSA levels of 4.0 ng/mL or less and T1c disease.
    Freedland SJ; Mangold LA; Epstein JI; Partin AW
    Urology; 2004 May; 63(5):887-91. PubMed ID: 15134972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.